- QMRO Home
- Barts Cancer Institute
- Centre for Molecular Oncology
- Site-specific stabilization of minigastrin analogs against enzymatic degradation for enhanced cholecystokinin-2 receptor targeting (vol 8, pg 2896, 2018)
Browse
Administrators only